Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data

Alalawneh, Majdoleen; Rachid, Ousama; Abdallah, Ibtihal; Mahfouz, Ahmed; Elewa, Hazem; Danjuma, Mohammed Ibn-Mas‘ud; Mohamed, Asmaa Ezzeldin; Awaisu, Ahmed

doi:10.1007/s00228-023-03572-7

Metrics

Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data

Last updated: Thu, 4 Dec 2025 6:32:34 UTC

Accesses

Accesses is an approximate count of unique views and downloads. This number can fluctuate depending on multiple factors.

We update counts daily.

1846 Accesses

Citations

Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.

3Citations

Altmetric

1 tweeters
17 Mendeley

Altmetric calculates a score based on the online attention an article gets — the higher the score, the more online attention an article has received.

Surrounding the score can be 1 or more colours. Each colour represents a different type of online attention, like social media or news outlets.

Older articles have had more time to get noticed, so Altmetric provides context data for articles of a similar age.

This article is in the 19^th percentile (ranked 187,794^th) of the 275,721 tracked articles of a similar age in all journals and the 28^th percentile (ranked 11^th) of the 14 tracked articles of a similar age in European Journal of Clinical Pharmacology.

View more on Altmetric.

Back to article page